SARS-CoV-2 Diagnostic Tests: Algorithm and Field Evaluation From the Near Patient Testing to the Automated Diagnostic Platform

Frontiers in Medicine

Nathalie De Vos¹  Cecile Duterme¹  Frédéric Cotton¹  Fanny Ponthieux¹  Charlotte Martin²  Nicolas Yin³  Hafid Dahma³  Magali Wautier³  Cyril Debuysschere³  Marie Hallin⁴  Vincent Collot⁵  Fatima-Zohra Bouazza⁵  Stefano Malinverni⁵  Magali Bartiaux⁵  Marc Decroly⁶  Marie-Luce Delforge⁷  Marius Gilbert⁸ 

[1] Department of Clinical Chemistry, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium;Department of Infectious Diseases, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium;Department of Microbiology, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium;Department of Microbiology, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium;Center for Environmental Health and Occupational Health, Public Health School, Université Libre de Bruxelles, Brussels, Belgium;Emergency Department, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium;General Practitioner, Brussels, Belgium;Institut de Biologie Clinique, Université Libre de Bruxelles, Brussels, Belgium;Spatial Epidemiology Laboratory, Université Libre de Bruxelles, Brussels, Belgium;

关键词: COVID-19;    SARS-CoV-2;    immunoassay;    diagnostic;    antigen;    PCR;    point-of-care;    NAAT;   

DOI  :  10.3389/fmed.2021.650581

来源: Frontiers

【 授权许可】

CC BY